Abstract P085: Cardiometabolic Syndrome Varies Significantly by Geography and Race/Ethnicity
Introduction: The relationship between cardiometabolic syndrome (CMS) and various risk factors has been studied in a variety of populations. Previously published research using 2007 Behavioral Risk Factor Surveillance System (BRFSS) data from Pennsylvania found that black and Hispanic adults had a significantly higher prevalence of CMS compared with whites. However, CMS has not been presented at the state level for the purpose of comparing the prevalence between states and between subpopulations within states.
Hypothesis: This descriptive study examines the variation in prevalence of CMS by state and by race/ethnicity. We assessed the hypothesis that significant racial disparities exist in CMS prevalence between and within states.
Methods: The sample size for this study included 2,380,047 noninstitutionalized adults aged 18 and older. A composite variable for CMS was created using BRFSS variables measuring obesity, hypercholesterolemia, angina (as a proxy for decreased high-density lipoprotein), prehypertension or hypertension, and prediabetes or diabetes. CMS was defined as having 3 or more of the 5 variables. Within BRFSS, obesity is defined as having a body mass index >=30kg/m*m based on self-reported height and weight. . Self-reported diagnosis of high cholesterol was used as a surrogate for elevated triglycerides. Self-reported diagnosis of angina or CHD was used as a surrogate for reduced HDL. Five years of BRFSS data (2011-2015) were aggregated to ensure adequate sample size for stratification by demographic variables. The survey weight used in the analysis was adjusted to represent the average population over the 5-year period. Both unadjusted and age-adjusted prevalence estimates were calculated. All statistical analyses were performed using STATA v14.1.
Results: Unadjusted prevalence of cardiometabolic syndrome varied from 10.5% (95% CI: 10.0%-10.9%) of adults in Colorado to 23.1% (95% CI: 22.3%-24.0%) in Mississippi. Within Colorado, prevalence of CMS was 7.7% (95% CI: 7.2%-8.1%) among adults aged 18 to 64, and 21.7% (95% CI: 20.7%-22.7%) among adults aged 65 and older. In Mississippi prevalence of CMS was 19.8% (95% CI: 18.8%-20.7%) among adults aged 18 to 64 and 34.3% (95% CI: 32.8%-35.8%) among adults aged 65 and older. CMS prevalence is significantly higher among black adults compared with whites and Hispanics in almost all states (unadjusted for age). Age-adjusted comparisons between states are presented.
Conclusions: Understanding the burden of CMS relative to other states and among select demographic groups within the state is vital to prevention efforts. Black adults are disproportionately afflicted with poor cardiometabolic health and the degree of affliction is dependent on state of residence. In conclusion, when it comes to CMS, it matters where you live, your age, and your racial/ethnic status.
Author Disclosures: L. Houghtaling: G. Consultant/Advisory Board; Significant; United Health Foundation. S. Milder: G. Consultant/Advisory Board; Significant; United Health Foundation. T. Eckstein: G. Consultant/Advisory Board; Significant; United Health Foundation.
- © 2017 by American Heart Association, Inc.